Pharmaceuticals Acquisitions in Nevada

Showing 1 transactions.

  • Oragenics Acquires Odyssey Health Neurological Drug Assets
    January 2, 2024
    Buyer
    Oragenics, Inc.
    Target
    Odyssey Health, Inc. (neurological assets)
    Seller
    Odyssey Health, Inc.
    Industry
    Pharmaceuticals
    Location
    Nevada, United States
    Type
    Divestiture

    Oragenics, Inc. completed the acquisition of Odyssey Health, Inc.'s neurological drug therapy assets, including ONP-002, ONP-001 rights, a proprietary intranasal delivery device and related formulations. Odyssey retained its remaining assets and operations; Michael Redmond (former Odyssey CEO) was named President of Oragenics to oversee integration and advancement of the neurology pipeline as Oragenics prepares for Phase 2 studies of ONP-002.

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.

Start Free Trial →